Effectiveness of Different Methods in Acute Myofascial Pain Syndrome

Myofacial Pain Syndromes Clinical Trial

Official title:

Effectiveness of 3 Different Methods in Acute Myofascial Pain Syndrome: A Randomized Controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04827303
• Other study ID #: 29032017-8
• Status: Completed
• Start date: April 1, 2017
• Est. completion date: April 1, 2019

Study information

• Verified date: March 2021
• Source: Ufuk University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is a randomized controlled study. A total of 75 patients between the ages of 20-50 who have a diagnosis of acute myofacial pain syndrome in the trapezius muscle and have pain for a maximum of 5 days were included in the study. Patients were randomly divided into 3 groups. Group 1 patients received kinesio tape method (25 patients), group 2 patients received trigger point injection method (25 patients), and group 3 patients received neural therapy injection method (25 patients). A 10-15 cm sized I band was applied to the trapezius muscles of the first group patients with the patient's neck in lateral flexion. Then, while the patient's neck is flexed, a Y-shaped 15-20 cm tape will be affixed between C1-7 with the arms of the Y up, and I tape of 5-10 cm is attached on the arms. In group 2 patients, 1 cc lidocaine diluted with 4 cc saline (SF) was applied to the trigger points palpated manually in the trapezius muscles. After the trigger point was squeezed between the thumb and index finger, a few cc of local anesthetic mixture was applied into the trigger point with the injector and exited. In the 3rd group patients, a few cc local anesthetic mixture will be applied intradermally over the trigger point without entering into the trigger points palpated manually in the trapezius muscles. Patients were checked 72 hours and 1 week after the first applications.

The pain at rest and during movement of the patients in all 3 groups were evaluated with a visual analog scale (VAS 10 cm). The number of trigger points was determined by the physician by hand palpation. Pressure pain threshold was evaluated with the algometer device. Disability assessment of the patients was made using the neck pain disability index. evaluations were made at the beginning of treatment, 72 hours after and 1 week after treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: April 1, 2019
• Est. primary completion date: April 1, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 50 Years

Eligibility

Inclusion Criteria:

• Patients diagnosed with acute myofascial pain syndrome

• Patients between the ages of 20-50

• Patients with pain for up to 5 days

Exclusion Criteria:

• Patients diagnosed with fibromyalgia

• Patients with systemic disease

• Patients with prominent cervical disc herniation

• Patients with cervical arthrosis

• Patients with cervical radiculopathy and myelopathy

• Patients with myofascial trigger point injection in the past 6 months

• Patients who received physical therapy in the past 6 months

• Patients undergoing shoulder and neck surgery

• Patients with drug allergies

Related Conditions & MeSH terms

• Facial Neuralgia
• Facial Pain
• Fibromyalgia
• Myofacial Pain Syndromes
• Myofascial Pain Syndromes
• Somatoform Disorders
• Syndrome

Intervention

Other:
• Kinesio taping
A 10-15 cm sized I band was applied to the trapezius muscles of the first group patients with the patient's neck in lateral flexion. Then, while the patient's neck is flexed, a Y-shaped 15-20 cm tape will be affixed between C1-7 with the arms of the Y up, and I tape of 5-10 cm is attached on the arms. In group 2 patients, 1 cc lidocaine diluted with 4 cc saline (SF) was applied to the trigger points palpated manually in the trapezius muscles. After the trigger point was squeezed between the thumb and index finger, a few cc of local anesthetic mixture was applied into the trigger point with the injector and exited. In the 3rd group patients, a few cc local anesthetic mixture will be applied intradermally over the trigger point without entering into the trigger points palpated manually in the trapezius muscles. Patients were checked 72 hours and 1 week after the first applications.

Locations

Country	Name	City	State
Turkey	Ufuk University	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Ufuk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual analog scale	The pain at rest and during movement of the patients in all 3 groups were evaluated with a visual analog scale (VAS 10 cm).	1 week
Primary	The number of trigger points	The number of trigger points was determined by the physician by hand palpation.	1 week
Primary	Pressure pain threshold	Pressure pain threshold was evaluated with the algometer device.	1 week
Primary	Neck pain disability index	Disability assessment of the patients was made using the neck pain disability index.	1 week